202 related articles for article (PubMed ID: 23742974)
1. Effects of pharmaceutical excipients on membrane permeability in rat small intestine.
Takizawa Y; Kishimoto H; Nakagawa M; Sakamoto N; Tobe Y; Furuya T; Tomita M; Hayashi M
Int J Pharm; 2013 Sep; 453(2):363-70. PubMed ID: 23742974
[TBL] [Abstract][Full Text] [Related]
2. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
3. Influene of Pharmaceutical Excipients on the Membrane Transport of a P-glycoprotein Substrate in the Rat Small Intestine.
Takizawa Y; Goto N; Furuya T; Hayashi M
Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):645-652. PubMed ID: 32583315
[TBL] [Abstract][Full Text] [Related]
4. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
[TBL] [Abstract][Full Text] [Related]
5. Increased membrane permeation and blood concentration of 6-carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model rats.
Kumagai M; Ishii M; Morimoto K; Tomita M
Biopharm Drug Dispos; 2020 Mar; 41(3):91-100. PubMed ID: 32043274
[TBL] [Abstract][Full Text] [Related]
6. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of reversible absorption-enhancing effect of sodium nitroprusside in rat small intestine.
Takizawa Y; Kishimoto H; Kitazato T; Ishizaka H; Kamiya N; Ito Y; Tomita M; Hayashi M
Eur J Pharm Sci; 2013 Jul; 49(4):664-70. PubMed ID: 23707468
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different intestinal epithelia as models for absorption enhancement studies.
Legen I; Salobir M; Kerc J
Int J Pharm; 2005 Mar; 291(1-2):183-8. PubMed ID: 15707745
[TBL] [Abstract][Full Text] [Related]
9. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.
Lacombe O; Woodley J; Solleux C; Delbos JM; Boursier-Neyret C; Houin G
Eur J Pharm Sci; 2004 Dec; 23(4-5):385-91. PubMed ID: 15567292
[TBL] [Abstract][Full Text] [Related]
10. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G
Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937
[TBL] [Abstract][Full Text] [Related]
11. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
Hamid KA; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2009 Sep; 379(1):100-8. PubMed ID: 19555752
[TBL] [Abstract][Full Text] [Related]
12. New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments.
Tran HT; Tran PH; Lee BJ
Int J Pharm; 2009 Aug; 378(1-2):9-16. PubMed ID: 19465096
[TBL] [Abstract][Full Text] [Related]
13. [Effect of Glycyrrhiza inflata and Daphne genkwa on permeabilities of rhodamine 123, a P-glycoprotein substrate across rat jejunum membranes in vitro].
Huang BB; Li GF; Ren F; Tang ZK; Ma HF; Sun YB; Chen LJ; Yang L
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(21):2521-6. PubMed ID: 19149264
[TBL] [Abstract][Full Text] [Related]
14. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
15. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.
Lo YL
J Control Release; 2003 Jun; 90(1):37-48. PubMed ID: 12767705
[TBL] [Abstract][Full Text] [Related]
16. Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats.
Ruiz-Picazo A; Gonzalez-Alvarez M; Gonzalez-Alvarez I; Bermejo M
Mol Pharm; 2020 Jul; 17(7):2310-2318. PubMed ID: 32469522
[TBL] [Abstract][Full Text] [Related]
17. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.
Mudra DR; Borchardt RT
J Pharm Sci; 2010 Feb; 99(2):1016-27. PubMed ID: 19650119
[TBL] [Abstract][Full Text] [Related]
18. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
Avdeef A; Kansy M; Bendels S; Tsinman K
Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735
[TBL] [Abstract][Full Text] [Related]
19. Systematic studies on the paracellular permeation of model permeants and oligonucleotides in the rat small intestine with chenodeoxycholate as enhancer.
Tsutsumi K; Li SK; Hymas RV; Teng CL; Tillman LG; Hardee GE; Higuchi WI; Ho NF
J Pharm Sci; 2008 Jan; 97(1):350-67. PubMed ID: 17847071
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin.
Legen I; Kracun M; Salobir M; Kerc J
Int J Pharm; 2006 Feb; 308(1-2):84-9. PubMed ID: 16330171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
